SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 121 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $201,000 | -18.3% | 8,142 | -49.5% | 0.01% | -20.0% |
| Q1 2016 | $246,000 | -74.5% | 16,135 | -77.5% | 0.01% | -73.7% |
| Q4 2015 | $963,000 | +59.4% | 71,618 | +66.3% | 0.04% | +35.7% |
| Q3 2015 | $604,000 | +141.6% | 43,055 | +43.0% | 0.03% | +250.0% |
| Q4 2014 | $250,000 | -15.3% | 30,115 | -8.6% | 0.01% | 0.0% |
| Q1 2014 | $295,000 | – | 32,948 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |